in vitro studies showed that Decitabine could inhibit the function of MYC gene by up-regulating the expression of ID2 [16] and synergistically suppressing the proliferation of diffuse large B cell lymphoma cell lines with HDAC inhibitor Panobinostat [17]. The gene discussed is HDAC9; the disease is diffuse large B-cell lymphoma.